Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Maskey-Warzechowska, J. Domagala-Kulawik, T. Urbankowski, P. Nejman-Gryz, R. Krenke, R. Chazan (Warsaw, Poland). The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3790

Member's Comments

No comment yet.

Related content which might interest you: Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis Source: Annual Congress 2012 - Sarcoidosis Year: 2012 Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Which BAL fluid (BALF) analyses are clinically useful in immunocomptent children? Source: Annual Congress 2013 –Paediatric bronchology Year: 2013 The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Bronchoalveolar lavage (BAL) to monitor disease progression Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis Year: 2012 Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Characterization of inflammation in bronchoalveolar lavage of lung transplant patients Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Bronchoalveolar lavage in children with diffuse lung disease Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Experiences with bronchoalveolar lavage (BAL) in children Source: Eur Respir J 2004; 24: Suppl. 48, 399s Year: 2004 Utility of bronchoalveolar lavage in vasculitis patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002